Join us this week with Innosphere for a focused discussion on Best Practices When Pitching to Life Science Investors and Industry Partners. Whether you are an emerging biopharma company or have a breakthrough idea for a digital health app, understanding the nuances of the life science venture capital environment is critical in setting your company up for success. Through this session, you will learn about the different types of life science investors, how to prepare for an outreach, how to develop a “killer” pitch deck, and gain insights on the partnering process. Learn more about the lunch & learn, featuring firm partner Brent Fassett and chief business advisor Matthew Meyer here.
Mikayla Kurland
mkurland@wsgr.com
Brent Fassett is a corporate partner in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he represents emerging growth companies and the investors that support them, focusing on the life sciences and medical technology industries. He specializes in venture capital financings, public and private merger and acquisition transactions, IPOs, licensing and commercial agreements, employee compensation plans, public company reporting and disclosure issues, and securities law compliance.
Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.